Vera Therapeutics (VERA) Other Non-Current Assets (2020 - 2026)

Vera Therapeutics (VERA) has 6 years of Other Non-Current Assets data on file, last reported at $1.2 million in Q1 2026.

• Quarterly Other Non-Current Assets rose 917.54% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (up 917.54% YoY) and the FY2025 annual result came in at $5.8 million, up 4365.65% from the prior year.
• Other Non-Current Assets retreated to $1.2 million in Q1 2026, from $5.8 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $5.8 million in Q4 2025 to a low of $67000.0 in Q1 2022.
• A 5-year average of $1.0 million and a median of $460000.0 in 2024 frame the typical range for Other Non-Current Assets.
• Annual changes were most pronounced in 2022 — Other Non-Current Assets tumbled 77.13% — and 2025, when it surged 4365.65%.
• Tracing VERA's Other Non-Current Assets over 5 years: stood at $293000.0 in 2022, then surged by 64.51% to $482000.0 in 2023, then plunged by 72.82% to $131000.0 in 2024, then surged by 4365.65% to $5.8 million in 2025, then tumbled by 80.17% to $1.2 million in 2026.
• The last three Other Non-Current Assets figures came in at $1.2 million (Q1 2026), $5.8 million (Q4 2025), and $3.0 million (Q3 2025), per Business Quant data.